Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
about
Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.The Phosphatidylinositol 3-kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells.Somatic mutations in salivary duct carcinoma and potential therapeutic targets.Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin
P2860
Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphatidyl inositol-3 kinase ...... type in cervical cancer cells.
@en
Phosphatidyl inositol-3 kinase
@nl
type
label
Phosphatidyl inositol-3 kinase ...... type in cervical cancer cells.
@en
Phosphatidyl inositol-3 kinase
@nl
prefLabel
Phosphatidyl inositol-3 kinase ...... type in cervical cancer cells.
@en
Phosphatidyl inositol-3 kinase
@nl
P2093
P2860
P356
P1433
P1476
Phosphatidyl inositol-3 kinase ...... type in cervical cancer cells.
@en
P2093
Cole D Merry
Corinne M Doll
Elias Saba
Elizabeth Kornaga
John B McIntyre
Prafull Ghatage
Shujuan Fang
Susan P Lees-Miller
Wani Arjumand
P2860
P304
82424-82439
P356
10.18632/ONCOTARGET.10955
P407
P577
2016-07-30T00:00:00Z